168 related articles for article (PubMed ID: 3284830)
1. Evaluation of the activity of the carbocysteine-sobrerol combination on mucus spinnability.
Distefano SM; Palermo F; Crimi N; Mistretta A; Pamparana F; Messa A
Int J Clin Pharmacol Res; 1988; 8(1):31-5. PubMed ID: 3284830
[TBL] [Abstract][Full Text] [Related]
2. Review on sobrerol as a muco-modifying drug: experimental data and clinical findings in hypersecretory bronchopulmonary diseases.
Braga PC; Allegra L; Bossi R; Scuri R; Castiglioni CL; Romandini S
Int J Clin Pharmacol Res; 1987; 7(5):381-400. PubMed ID: 3312046
[TBL] [Abstract][Full Text] [Related]
3. Double-blind clinical trial of domiodol vs S-carboxymethylcysteine in chronic obstructive lung disease.
Casali L; Rampulla C; Rossi A
Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):554-7. PubMed ID: 6757153
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the elastic and viscous components of bronchial mucus before and after S-carboxymethylcysteine-Lys treatment.
Braga PC; Bossi R; Allegra L
Int J Clin Pharmacol Res; 1984; 4(2):121-7. PubMed ID: 6469438
[TBL] [Abstract][Full Text] [Related]
5. No demonstrable effect of sobrerol as an expectorant in patients with stable chronic bronchial diseases.
Medici TC; Shang H; Grosgurin P; Berg P; Achermann R; Wehrli R
Bull Eur Physiopathol Respir; 1985; 21(6):477-83. PubMed ID: 3907738
[TBL] [Abstract][Full Text] [Related]
6. Influence of tasuldine and acetylcysteine on mucociliary clearance in patients with chronic airways obstruction.
Dorow P; Weiss T; Felix R; Köhler M
Arzneimittelforschung; 1986; 36(1):131-3. PubMed ID: 3954815
[TBL] [Abstract][Full Text] [Related]
7. Identification of subpopulations of bronchitic patients for suitable therapy by a dynamic rheological test.
Braga PC; Allegra L; Bossi R; Guffanti EE; Scarpazza G; Bisetti A; Spada E; Fumagalli G
Int J Clin Pharmacol Res; 1989; 9(3):175-82. PubMed ID: 2744910
[TBL] [Abstract][Full Text] [Related]
8. The effect and mechanism of action of carbocysteine on airway bacterial load in rats chronically exposed to cigarette smoke.
Sun L; Tang L; Xu Y; Wang S; Li Y; Kang J
Respirology; 2010 Oct; 15(7):1064-71. PubMed ID: 20807377
[TBL] [Abstract][Full Text] [Related]
9. [Mucolytic agents. Polycentric study of a carbocysteine-sobrerol combination].
Gramiccioni E; Pamparana F; Messa A
Arch Monaldi Mal Torace; 1989; 44(4-6):791-3. PubMed ID: 2577796
[No Abstract] [Full Text] [Related]
10. Action of sobrerol on mucociliary transport.
Allegra L; Bossi R; Braga PC
Respiration; 1981; 42(2):105-9. PubMed ID: 7313328
[TBL] [Abstract][Full Text] [Related]
11. [Carbocysteine-sobrerol combination and exacerbation of chronic bronchitis].
Pasturenzi L; Donnetta AM; Gualtieri G; Luisetti M
Arch Monaldi Mal Torace; 1988; 43(6):487-505. PubMed ID: 3155012
[No Abstract] [Full Text] [Related]
12. [Efficacy of the simultaneous aerosol administration of fenoterol and 2(alpha-thenoylthio)propionylglycine].
Ardizzi A; Della Toffola A; Galietti F; Giorgis GE; Miravalle C; Oliaro A; Scappaticci E
Minerva Med; 1986 Oct; 77(39):1823-6. PubMed ID: 3534632
[TBL] [Abstract][Full Text] [Related]
13. [Further study on the possibility of using carbocysteine in cystic fibrosis].
Ferraris S; Zannini G
Minerva Pediatr; 1983 Nov; 35(22):1145-50. PubMed ID: 6369102
[No Abstract] [Full Text] [Related]
14. Effects of S-carboxymethylcysteine on tracheal mucus velocity.
Goodman RM; Yergin BM; Sackner MA
Chest; 1978 Dec; 74(6):615-8. PubMed ID: 367726
[TBL] [Abstract][Full Text] [Related]
15. No demonstrable effect of S-carboxymethylcysteine on clearance of secretions from the human lung.
Thomson ML; Pavia D; Jones CJ; McQuiston TA
Thorax; 1975 Dec; 30(6):669-73. PubMed ID: 769242
[TBL] [Abstract][Full Text] [Related]
16. Clinical evaluation of new therapies for treatment of mucus hypersecretion in respiratory diseases.
Disse B
Novartis Found Symp; 2002; 248():254-72; discussion 272-6, 277-82. PubMed ID: 12568499
[TBL] [Abstract][Full Text] [Related]
17. Almitrine bismesylate: a long-term placebo-controlled double-blind study in COAD--Vectarion International Multicentre Study Group.
Voisin C; Howard P; Ansquer JC
Bull Eur Physiopathol Respir; 1987 Aug; 23 Suppl 11():169s-182s. PubMed ID: 3318971
[TBL] [Abstract][Full Text] [Related]
18. Comparison between penetration of amoxicillin combined with carbocysteine and amoxicillin alone in pathological bronchial secretions and pulmonary tissue.
Braga PC; Scaglione F; Scarpazza G; Fraticelli G; Roviaro G; Varoli F; Mariani C; Falchi M; Fraschini F
Int J Clin Pharmacol Res; 1985; 5(5):331-40. PubMed ID: 4066083
[TBL] [Abstract][Full Text] [Related]
19. [Comparative clinical evaluation of two mucolytic agents: S-carboxy-methyl-cysteine and letosteine (author's transl)].
Blaive B; Lapalus P; Lemoigne F
Sem Hop; 1978 Oct 8-15; 54(29-32):983-6. PubMed ID: 216094
[TBL] [Abstract][Full Text] [Related]
20. [Clinical use of the combination prenoxidiazine-S-carboxy-methyl-cysteine].
Alesina R; Caliandro L; Cerveri I; Scala C
G Clin Med; 1979 Feb; 60(2):136-54. PubMed ID: 378746
[No Abstract] [Full Text] [Related]
[Next] [New Search]
